Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020

Breakthrough candidemia (BrC) is a significant problem in immunocompromised patients, particularly those with hematological disorders. To assess the characteristics of BrC in patients with hematologic disease treated with novel antifungal agents, we collected clinical and microbiological information...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Ruriko, Eriguchi, Yoshihiro, Miyake, Noriko, Nagasaki, Yoji, Yonekawa, Akiko, Mori, Yasuo, Kato, Koji, Akashi, Koichi, Shimono, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294639/
https://www.ncbi.nlm.nih.gov/pubmed/37312399
http://dx.doi.org/10.1093/mmy/myad056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294639/
https://www.ncbi.nlm.nih.gov/pubmed/37312399
http://dx.doi.org/10.1093/mmy/myad056

Ejemplares similares